# The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study

> **NCT06846775** · — · RECRUITING · sponsor: **University of Aarhus** · enrollment: 120 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DIAGNOSTIC_TEST:** DNA-methylation testing in patient-collected urine and vaginal samples

## Key facts

- **NCT ID:** NCT06846775
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2026-02-28
- **Final completion:** 2028-01-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-01-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06846775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06846775, "The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06846775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*